Although the BRCA1 (NM_007294.3) and BRCA2 (NM_000059.3) gene variants were the primary focus of such studies in the past, hereditary cancer panel testing has recently replaced the approach involving only the BRCA1 and BRCA2 genes. The gene discussed is BRCA2; the disease is hereditary cancer.